Skip to content
★ Sign in to follow
DT

Dean Tozer

Executive
Nuo Therapeutics, Inc.
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€59k
▼ Sales (0 ops.)
—

Latest filing published 08 Oct 2014 for Nuo Therapeutics, Inc., €9,480.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Dean Tozer: trading record in brief

Dean Tozer discloses dealings in Nuo Therapeutics, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 20 August 2014 to 6 October 2014.

On the market, this insider has only ever bought: 5 purchases, €59k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

Half of the purchases are above €11k and half below.

The latest filing, published on 8 October 2014, reports an open-market purchase of €9,480 in Nuo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Dean Tozer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    Chief Commercial OfficerExecutivesNuo Therapeutics, Inc.
    11,988 USD0SEC
    33,300 shares@ US$0.36Common StockSEC:0001144204-14-060242:0
    Canonical exit: 4 Jan 2015 (T+90)
  • ▲
    Chief Commercial OfficerExecutivesNuo Therapeutics, Inc.
    18,000 USD0SEC
    40,000 shares@ US$0.45Common StockSEC:0001144204-14-056271:0
    Canonical exit: 11 Dec 2014 (T+90)
  • ▲
    Chief Commercial OfficerExecutivesNuo Therapeutics, Inc.
    14,000 USD0SEC
    40,000 shares@ US$0.35Common StockSEC:0001144204-14-053767:0
    Canonical exit: 27 Nov 2014 (T+90)
  • ▲
    Chief Commercial OfficerExecutivesNuo Therapeutics, Inc.
    14,706 USD0SEC
    38,700 shares@ US$0.38Common StockSEC:0001144204-14-052326:0
    Canonical exit: 20 Nov 2014 (T+90)
  • ▲
    Chief Commercial OfficerExecutivesNuo Therapeutics, Inc.
    18,720 USD0SEC
    48,000 shares@ US$0.39Common StockSEC:0001144204-14-051967:0
    Canonical exit: 18 Nov 2014 (T+90)

5 of 5 declarations